Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine.

Glueck CJ, Jetty V, Rothschild M, Duhon G, Shah P, Prince M, Lee K, Goldenberg M, Kumar A, Goldenberg N, Wang P.

N Am J Med Sci. 2016 Jul;8(7):284-90. doi: 10.4103/1947-2714.187137.

2.

Epigenetic associations in relation to cardiovascular prevention and therapeutics.

Voelter-Mahlknecht S.

Clin Epigenetics. 2016 Jan 15;8:4. doi: 10.1186/s13148-016-0170-0. eCollection 2016 Jan 15. Review.

3.

Functional Outcome After Lower Limb Amputation: Is Hyperhomocysteinemia a Predictive Factor?: An Observational Study.

Brunelli S, Fusco A, Iosa M, Ricciardi E, Traballesi M.

Medicine (Baltimore). 2015 Dec;94(49):e2167. doi: 10.1097/MD.0000000000002167.

4.

N-homocysteinylation induces different structural and functional consequences on acidic and basic proteins.

Sharma GS, Kumar T, Singh LR.

PLoS One. 2014 Dec 31;9(12):e116386. doi: 10.1371/journal.pone.0116386. eCollection 2014 Dec 31.

5.

Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia.

Nishi A, Numata S, Tajima A, Kinoshita M, Kikuchi K, Shimodera S, Tomotake M, Ohi K, Hashimoto R, Imoto I, Takeda M, Ohmori T.

Schizophr Bull. 2014 Sep;40(5):1154-63. doi: 10.1093/schbul/sbt154. Epub 2014 Feb 17.

6.

Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients.

van Overbeek EC, Staals J, van Oostenbrugge RJ.

PLoS One. 2013 Oct 14;8(10):e78100. doi: 10.1371/journal.pone.0078100. eCollection 2013 Oct 14.

7.

Stroke and nutrition: a review of studies.

Foroughi M, Akhavanzanjani M, Maghsoudi Z, Ghiasvand R, Khorvash F, Askari G.

Int J Prev Med. 2013 May;4(Suppl 2):S165-79.

8.

Vitamin B12 in health and disease.

O'Leary F, Samman S.

Nutrients. 2010 Mar;2(3):299-316. doi: 10.3390/nu2030299. Epub 2010 Mar 5. Review.

9.

Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT).

Troen AM, Scott TM, D'Anci KE, Moorthy D, Dobson B, Rogers G, Weiner DE, Levey AS, Dallal GE, Jacques PF, Selhub J, Rosenberg IH; FACT Study Investigators..

J Ren Nutr. 2012 Mar;22(2):268-76.e1-3. doi: 10.1053/j.jrn.2011.07.009. Epub 2011 Dec 6.

10.

Genetic linkage of serum homocysteine in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis.

Della-Morte D, Beecham A, Rundek T, Slifer S, Boden-Albala B, McClendon MS, Blanton SH, Sacco RL.

Stroke. 2010 Jul;41(7):1356-62. doi: 10.1161/STROKEAHA.109.573626. Epub 2010 May 20.

11.

MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate.

Lai CQ, Parnell LD, Troen AM, Shen J, Caouette H, Warodomwichit D, Lee YC, Crott JW, Qiu WQ, Rosenberg IH, Tucker KL, Ordovás JM.

Am J Clin Nutr. 2010 May;91(5):1377-86. doi: 10.3945/ajcn.2009.28923. Epub 2010 Mar 24.

12.

Homocysteine lowering interventions for preventing cardiovascular events.

Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006612. doi: 10.1002/14651858.CD006612.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD006612.

14.

B vitamins and cerebral ischemia.

Lorenzl S, Linnebank M, Stanger O.

Dtsch Arztebl Int. 2008 Feb;105(7):128-9; author reply 129. doi: 10.3238/arztebl.2008.0128c. Epub 2008 Feb 15. No abstract available.

15.
16.

Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.

Bushnell CD, Colón-Emeric CS.

Drugs Aging. 2009;26(3):209-30. doi: 10.2165/00002512-200926030-00003. Review.

17.

Increasing the number of SNP loci does not necessarily improve prediction power at least in the comparison of MTHFR SNP and haplotypes.

Miyaki K, Takahashi Y, Song Y, Zhang L, Muramatsu M, Nakayama T.

J Epidemiol. 2008;18(6):243-50. Epub 2008 Dec 9.

18.

Role of homocysteine in aortic calcification and osteogenic cell differentiation.

Van Campenhout A, Moran CS, Parr A, Clancy P, Rush C, Jakubowski H, Golledge J.

Atherosclerosis. 2009 Feb;202(2):557-66. doi: 10.1016/j.atherosclerosis.2008.05.031. Epub 2008 May 28.

19.

Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Urquhart BL, Freeman DJ, Cutler MJ, Mainra R, Spence JD, House AA.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1041-7. doi: 10.2215/CJN.04771107. Epub 2008 Mar 12.

20.

Supplemental Content

Support Center